Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.0806 per EA under NDC 69452036020. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Nov 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Bionpharma Inc.NDC
69452036020
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079229FDA Approved
11/28/2012
TE Code
AB
On Market Since
9/15/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0806 per EA |
|---|---|
| All-time high | $0.0977 (May 10, 2023) |
| All-time low | $0.0575 (Nov 20, 2024) |
| 52-week high | $0.0848 |
| 52-week low | $0.0795 |
| Median price | $0.0803 |
| Average price | $0.0797 |
| Largest weekly change | -28.2% (Nov 20, 2024) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ropinirole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Bionpharma Inc., is $0.0806 per EA (NDC 69452036020), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has declined 17.5%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since May 10, 2023, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0575 (Nov 20, 2024) to a high of $0.0977 (May 10, 2023), with a median of $0.0803 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ROPINIROLE HCL 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 69452036020) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.